Advertisements



Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More

Four pharma/biotech companies are set to release earnings .....»»

Category: personnelSource: nytApr 30th, 2018

Progenics Pharma"s Stock Down on Dismal Phase III Study Data

Progenics Pharmaceuticals' (PGNX) shares down on disappointing results from phase III study evaluating imaging agent, 1404, for prostate cancer detection. .....»»

Category: worldSource: nyt4 hr. 47 min. ago

The Daily Biotech Pulse: Johnson & Johnson"s Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 18.) read more.....»»

Category: blogSource: benzingaSep 19th, 2018

This cancer-fighting biotech sped from startup to IPO filing in 10 months

The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»

Category: topSource: bizjournalsSep 17th, 2018

Pharma veteran Jackie Fouse is leaving a SoftBank-backed biotech founded by a 33-year-old to run a cancer drugmaker

Courtesy Agios Pharma veteran Jackie Fouse.....»»

Category: topSource: businessinsiderSep 4th, 2018

The Daily Biotech Pulse: FDA Blessings for Merck"s HIV Drug Combo, Veracyte"s Test Gets Medicare Coverage

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 30) Acceleron Pharma .....»»

Category: earningsSource: benzingaAug 31st, 2018

The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace"s Offering, Dexcom Buys TypeZero

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 22) read more.....»»

Category: blogSource: benzingaAug 23rd, 2018

The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace"s Offering, Dexcom Buys TypeZero

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 22) Acer Therapeutics Inc (NASDAQ: ACER) Avanos Medical Inc (NYSE: AVNS) CareDx.....»»

Category: earningsSource: benzingaAug 23rd, 2018

8 Undervalued Biotech Stocks to Watch

InvestorPlace - Stock.....»»

Category: topSource: investorplaceAug 20th, 2018

BMO, Oppenheimer Out Bullish On Constellation Pharma"s Cancer Treatment Opportunity

The development-stage biotechnology company Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) uses protein interaction to treat myelofibrosis, in addition to addressing prostate cancer and other tumors. Latest Ratings for CNST DateF.....»»

Category: blogSource: benzingaAug 13th, 2018

Pluristem Therapeutics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation

With hundreds of biotech stocks all assuring big prospects, building a portfolio of truly transformative medicine makers is a feat. B. Riley FBR said it's found two winners.  Latest .....»»

Category: blogSource: benzingaJul 31st, 2018

Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT

Let's see how pharma/biotech stocks.....»»

Category: smallbizSource: nytJul 30th, 2018

4 Biotech Bets to Watch as Industry Rebounds in a Month

The biotech sector makes a sharp rise in 30 days post the positive data read out from Biogen's mid-stage Alzheimer's trial on BAN2401. We recommend a few industry playe.....»»

Category: personnelSource: nytJul 20th, 2018

Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Category: personnelSource: nytJul 20th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Biotech stocks held their ground in a holiday-shortened week amid a drought of market-moving catalysts. Looking ahead, the following are catalytic events for biotech investors to watch.  read more.....»»

Category: blogSource: benzingaJul 8th, 2018

Benzinga"s Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index

Here's a roundup of top developments in the biotech space since Tuesday morning. Scaling the Peaks (Stocks hitting 52-week highs on July 3) read more.....»»

Category: blogSource: benzingaJul 5th, 2018

Your Daily Pharma Scoop: Review Of 3 More Stocks From The Biotech Boom IPO Week (18 - 22 June)

Your Daily Pharma Scoop: Review Of 3 More Stocks From The Biotech Boom IPO Week (18 - 22 June).....»»

Category: topSource: seekingalphaJul 4th, 2018

Benzinga"s Daily Biotech Pulse: Titan"s Parkinson"s Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 2) read more.....»»

Category: blogSource: benzingaJul 3rd, 2018

Your Daily Pharma Scoop: Review Of 3 Stocks From The Biotech Boom IPO Week (18 - 22 June)

Your Daily Pharma Scoop: Review Of 3 Stocks From The Biotech Boom IPO Week (18 - 22 June).....»»

Category: topSource: seekingalphaJun 25th, 2018

8 Energy Stocks To Watch Ahead Of OPEC Meetings

The United States Oil Fund LP (ETF) (NYSE: USO) is down 7.6 percent in the past month as investors anticipate the next major OPEC meeting this week. read more.....»»

Category: blogSource: benzingaJun 21st, 2018